FOXP3+ Regulatory T Cells Use Heparanase To Access IL-2 Bound to ECM in Inflamed Tissues

Hunter A. Martinez, Ievgen Koliesnik, Gernot Kaber, Nadine Nagy, Graham Barlow, Ben A. Falk, Jacqueline K. Reid, Carlos O. Medina, Aviv Hargil, Israel Vlodavsky, Jin-ping Li, Magdiel Perez-Cruz, Sai-Wen Tang, Everett H. Meyer, Lucile E. Wrenshall, James D. Lord, K. Christopher Garcia, Theo D. Palmer, Lawrence Steinman, Gerald T. NepomThomas N. Wight, Paul L. Bollyky, Hedwich F. Kuipers

Research output: Contribution to journalArticle

Abstract

FOXP3+ regulatory T cells (Treg) depend on exogenous IL-2 for their survival and function, but circulating levels of IL-2 are low, making it unclear how Treg access this critical resource in vivo. Here, we show that Treg use heparanase (HPSE) to access IL-2 sequestered by heparan sulfate (HS) within the extracellular matrix (ECM) of inflamed central nervous system tissue. HPSE expression distinguishes human and murine Treg from conventional T cells and is regulated by the availability of IL-2. HPSE-/- Treg have impaired stability and function in vivo, including the experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis. Conversely, endowing Treg with HPSE enhances their ability to access HS-sequestered IL-2 and their tolerogenic function in vivo. Together, these data identify novel roles for HPSE and the ECM in immune tolerance, providing new avenues for improving Treg-based therapy of autoimmunity. ### Competing Interest Statement The authors have declared no competing interest.
Original languageAmerican English
Pages (from-to)2023.02.26.529772
JournalbioRxiv (revisions under review at Nature Communications)
StatePublished - 2023

Cite this